161 related articles for article (PubMed ID: 27246670)
1. Impact of Disease Management Programs on HbA1c Values in Type 2 Diabetes Patients in Germany.
Kostev K; Rockel T; Jacob L
J Diabetes Sci Technol; 2017 Jan; 11(1):117-122. PubMed ID: 27246670
[TBL] [Abstract][Full Text] [Related]
2. [Effect of the Disease Management Program on HbA1c Value in Type 2 Diabetes Mellitus Patients: A Retrospective Comparison between Disease Management Programs and Standard Care].
Wiefarn S; Kostev K; Heumann C; Rettelbach A
Dtsch Med Wochenschr; 2017 Oct; 142(21):e148-e155. PubMed ID: 28915520
[No Abstract] [Full Text] [Related]
3. Risk of Nonfatal Stroke in Type 2 Diabetes Mellitus Patients: A Retrospective Comparison Between Disease Management Programs and Standard Care.
Wiefarn S; Heumann C; Rettelbach A; Kostev K
J Diabetes Sci Technol; 2017 Jul; 11(4):808-813. PubMed ID: 28300432
[TBL] [Abstract][Full Text] [Related]
4. Prescription Patterns and the Cost of Antihyperglycemic Drugs in Patients With Type 2 Diabetes Mellitus in Germany.
Jacob L; von Vultee C; Kostev K
J Diabetes Sci Technol; 2017 Jan; 11(1):123-127. PubMed ID: 27402240
[TBL] [Abstract][Full Text] [Related]
5. Prescription Patterns and Disease Control in Type 2 Diabetes Mellitus Patients in Nursing Home and Home Care Settings: A Retrospective Analysis in Germany.
Kostev K; Rockel T; Jacob L
J Diabetes Sci Technol; 2018 Jan; 12(1):136-139. PubMed ID: 28539088
[TBL] [Abstract][Full Text] [Related]
6. Quality of diabetes care in Austrian diabetic patients willing to participate in a DMP - at baseline.
Flamm M; Winkler H; Panisch S; Kowatsch P; Klima G; Fürthauer B; Weitgasser R; Sönnichsen AC
Wien Klin Wochenschr; 2011 Jul; 123(13-14):436-43. PubMed ID: 21691756
[TBL] [Abstract][Full Text] [Related]
7. Time to Insulin Initiation in Type 2 Diabetes Patients in 2010/2011 and 2016/2017 in Germany.
Kostev K; Gölz S; Scholz BM; Kaiser M; Pscherer S
J Diabetes Sci Technol; 2019 Nov; 13(6):1129-1134. PubMed ID: 30862186
[TBL] [Abstract][Full Text] [Related]
8. Treatment Patterns in Patients With Newly Diagnosed Type 2 Diabetes in China: A Retrospective, Longitudinal Database Study.
Wang C; Gao Y; Zhu L; Huang M; Wu Y; Xuan J
Clin Ther; 2019 Aug; 41(8):1440-1452. PubMed ID: 31155146
[TBL] [Abstract][Full Text] [Related]
9. [General practitioners' perspectives on the perceived effectiveness of the disease management programs for type 2 diabetes and coronary heart disease: Results of a focus group study].
Pilic L; Molkentin K; Lehmann L; Herrmann A; Funke C; Müller BS; Bödecker AW; Redaèlli M; Wilm S
Z Evid Fortbild Qual Gesundhwes; 2024 Apr; 185():45-53. PubMed ID: 38418359
[TBL] [Abstract][Full Text] [Related]
10. Changes in Glycemic Control and Body Weight After Initiation of Dapagliflozin or Basal Insulin Supported Oral Therapy in Type 2 Diabetes: A Primary Care Database Study.
Kostev K; Pscherer S; Rist R; Busch S; Scheerer MF
J Diabetes Sci Technol; 2017 May; 11(3):590-596. PubMed ID: 28300454
[TBL] [Abstract][Full Text] [Related]
11. Patterns of glycaemic control in patients with type 2 diabetes mellitus initiating second-line therapy after metformin monotherapy: Retrospective data for 10 256 individuals from the United Kingdom and Germany.
Khunti K; Godec TR; Medina J; Garcia-Alvarez L; Hiller J; Gomes MB; Cid-Ruzafa J; Charbonnel B; Fenici P; Hammar N; Hashigami K; Kosiborod M; Nicolucci A; Shestakova MV; Ji L; Pocock S
Diabetes Obes Metab; 2018 Feb; 20(2):389-399. PubMed ID: 28817227
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of insulin as a first-line therapy and associated factors in people with type 2 diabetes in German primary care practices.
van den Boom L; Kaiser M; Kostev K
Diabet Med; 2020 Aug; 37(8):1333-1339. PubMed ID: 32506471
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal change in HbA1c in patients with type 2 diabetes: comparison of short-acting, biphasic and basal insulin.
Rathmann W; Strassburger K; Kostev K; Schröder-Bernhardi D; Giani G; Happich M
Exp Clin Endocrinol Diabetes; 2009 May; 117(5):230-3. PubMed ID: 19226479
[TBL] [Abstract][Full Text] [Related]
14. Diabetes treatment in people with type 2 diabetes and schizophrenia: Retrospective primary care database analyses.
Rathmann W; Pscherer S; Konrad M; Kostev K
Prim Care Diabetes; 2016 Feb; 10(1):36-40. PubMed ID: 25937183
[TBL] [Abstract][Full Text] [Related]
15. Intensification of antihyperglycemic therapy among patients with incident diabetes: a Surveillance Prevention and Management of Diabetes Mellitus (SUPREME-DM) study.
Raebel MA; Ellis JL; Schroeder EB; Xu S; O'Connor PJ; Segal JB; Butler MG; Schmittdiel JA; Kirchner HL; Goodrich GK; Lawrence JM; Nichols GA; Newton KM; Pathak RD; Steiner JF
Pharmacoepidemiol Drug Saf; 2014 Jul; 23(7):699-710. PubMed ID: 24639086
[TBL] [Abstract][Full Text] [Related]
16. Treatment Outcomes and Tolerability Following Initiation of GLP-1 Receptor Agonists Among Type 2 Diabetes Patients in Primary Care Practices in Germany.
Qiao Q; Johnsson K; Grandy S; Kostev K
J Diabetes Sci Technol; 2017 Mar; 11(2):272-277. PubMed ID: 27470665
[TBL] [Abstract][Full Text] [Related]
17. Randomized, open-label, parallel-group evaluations of basal-bolus therapy versus insulin lispro premixed therapy in patients with type 2 diabetes mellitus failing to achieve control with starter insulin treatment and continuing oral antihyperglycemic drugs: a noninferiority intensification substudy of the DURABLE trial.
Miser WF; Arakaki R; Jiang H; Scism-Bacon J; Anderson PW; Fahrbach JL
Clin Ther; 2010 May; 32(5):896-908. PubMed ID: 20685497
[TBL] [Abstract][Full Text] [Related]
18. Characteristics, management and attainment of lipid target levels in diabetic and cardiac patients enrolled in Disease Management Program versus those in routine care: LUTZ registry.
Bestehorn K; Jannowitz C; Karmann B; Pittrow D; Kirch W
BMC Public Health; 2009 Aug; 9():280. PubMed ID: 19653899
[TBL] [Abstract][Full Text] [Related]
19. Characteristics Associated with the Choice of First Injectable Therapy Among US Patients With Type 2 Diabetes.
Yu M; Mody R; Landó LF; Shui A; Kallenbach L; Slipski L; de Oliveira CP
Clin Ther; 2017 Dec; 39(12):2399-2408. PubMed ID: 29196084
[TBL] [Abstract][Full Text] [Related]
20. Glycaemic control among patients with type 2 diabetes mellitus in seven European countries: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) study.
Alvarez Guisasola F; Mavros P; Nocea G; Alemao E; Alexander CM; Yin D
Diabetes Obes Metab; 2008 Jun; 10 Suppl 1():8-15. PubMed ID: 18435669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
